Former Navy Surgeon General, Admiral Harold M. Koenig, M.D. Joins ProtoKinetix

ProtoKinetix, Inc., (OTCBB:PKTX) Board of Directors, takes pride in the appointment of the former Surgeon General of the United States Navy to its Scientific Advisory Board. Dr. Koenig served in the Office of the Secretary of Defense for Health under Presidents Bush and Clinton. The addition of Dr. Koenig to General Parker’s Science Advisory team gives a dramatic level of credibility to the Company’s interaction with the medical and health care community.

Science Advisory Chairman, General John Parker, M.D., commented, “Dr. Koenig is a significant and important addition to ProtoKinetix’ scientific team. He brings a wealth of scientific and political experience that adds depth and dimension to the strategic interests of the company.” ProtoKinetix’ CEO, Ross Senior, states, “Having an advisor the quality of Harold Koenig is invaluable to our current priority to fully integrate science and business affairs.”

“I am privileged to join John Parker and the other world-class scientists of ProtoKinetix. I believe in the far-reaching potential of their Anti-Aging Glyco Peptides and the revolutionary discovery of Geraldine Castelot-Deliencourt’s synthesized molecule. I believe that we may only be scratching the surface of the long-term contributions AAGP can make to medical science,” Koenig said.

Chairman of PKTX’s Business Advisory Board, Admiral Edward D. Martin, M.D., describes the appointment as “a perfect fit with our objectives to involve AAGP™ in military health care delivery systems and government partnerships.

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For more detailed information, on Admiral Koenig, M.D., please visit our website at: http://www.protokinetix.com/managementdirectors/bios/haroldkoenig/

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO

ProtoKinetix Inc.
Investor Contact
Blair Henderson, 604-687-9887